SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Park Hyon C.

(Last)

(First)

(Middle)

C/O TORRID HOLDINGS INC.

18501 EAST SAN JOSE AVENUE

(Street)

CITY OF INDUSTRY

91748

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/06/2024

3. Issuer Name and Ticker or Trading Symbol
Torrid Holdings Inc. [ CURV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	205,080⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option to purchase shares	⁽²⁾	08/22/2032	Common Stock	213,675	$5.99	D
Option to purchase shares	⁽³⁾	03/27/2033	Common Stock	90,207	$3.23	D
Option to purchase shares	⁽⁴⁾	04/02/2034	Common Stock	62,950	$4.51	D

Explanation of Responses:

1. Represents (1) 31,735 common stock shares outstanding , (2) 93,907 restricted stock units (RSUs) that remain unvested from an initial August 22, 2022 grant of 125,209 RSUs which started vesting on August 22, 2023, in an installment substantially equal to 25% of the grant, and will vest on August 22, 2024, August 22, 2025 and August 22, 2026, respectively; (3) 40,635 RSUs that remain unvested from a grant of 54,180 RSUs which started vesting on March 27, 2024, in an installment substantially equal to 25% of the grant, and will vest on March 27, 2025, March 27, 2026 and March 27, 2027, respectively; and (4) 38,803 RSUs, which will vest annually in substantially equal 25% installments on April 2, 2025, April 2, 2026, April 2, 2027 and April 2, 2028, subject to the reporting person's continued employment through the applicable vesting date.

2. Represents options to purchase shares that started vesting on August 22, 2023 and become exercisable in substantially equal 25% installments on August 22, 2023, August 22, 2024, August 22, 2025 and August 22, 2026, respectively, subject to the reporting person's continued employment through the applicable vesting date.

3. Represents options to purchase shares that started vesting on March 27, 2024 and become exercisable in substantially equal 25% installments on March 27, 2024, March 27, 2025, March 27, 2026 and March 27, 2027, respectively, subject to the reporting person's continued employment through the applicable vesting date.

4. Represents options to purchase shares that will start vesting on April 2, 2025 and become exercisable in substantially equal 25% installments on April 2, 2025, April 2, 2026, April 2, 2027 and April 2, 2028, respectively, subject to the reporting person's continued employment through the applicable vesting date.

Remarks:

Exhibit 24: Power of Attorney

	/s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Hyon Park	06/27/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.